logo logo
Search: Organ site Search: Tumor / Syndrome
WHO Classification of Tumours
WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart
Click for details
Travis WD, Brambilla E, Müller-Hermelink HK, Harris CC (Eds.)
World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart.
3rd Edition
IARC Press: Lyon 2004

C34 - Bronchus and lung:
The number attached to each tumour is the ICD-O morphology code of the International Classification of Diseases for Oncology (ICD-O) [1] and the Systematized Nomenclature of Medicine (http://snomed.org).
/0 benign tumours
/1 unspecified, borderline or uncertain behaviour
/2 in situ carcinomas
/3 malignant tumours.

1. Fritz A, Percy C, Jack A, Shanmuragatnam K, Sobin LH, Parkin DM, Whelan S (Eds) International Classification of Diseases for Oncology. World Health Organization: Geneva 2000

Malignant epithelial tumors
    8070/3 Squamous cell carcinoma, NOS
        8052/3 Papillary squamous cell carcinoma
        8084/3 Squamous cell carcinoma, clear cell type
        8073/3 Squamous cell carcinoma, small cell, nonkeratinizing
        8083/3 Basaloid squamous cell carcinoma

    8041/3 Small cell neuroendocrine carcinoma
        8045/3 Combined small cell carcinoma

    8140/3 Adenocarcinoma, NOS
        8255/3 Adenocarcinoma with mixed subtypes
        8550/3 Acinar cell carcinoma
        8260/3 Papillary adenocarcinoma, NOS
        8250/3 Bronchioloalveolar carcinoma, NOS
        8230/3 Solid carcinoma, NOS

    8012/3 Large cell carcinoma, NOS
        8013/3 Large cell neuroendocrine carcinoma
        8123/3 Basaloid carcinoma
        8082/3 Lymphoepithelial carcinoma
        8014/3 Large cell carcinoma with rhabdoid phenotype

    8560/3 Adenosquamous carcinoma

    8033/3 Sarcomatoid carcinoma
        8022/3 Pleomorphic carcinoma
        8032/3 Spindle cell carcinoma, NOS
        8031/3 Giant cell carcinoma
        8980/3 Carcinosarcoma, NOS
        8972/3 Pulmonary blastoma

    8240/3 Neuroendocrine tumor G1 (NET G1) / Carcinoid
    8249/3 Neuroendocrine tumor G2 (NET G2)

    Salivary gland tumors
        8430/3 Mucoepidermoid carcinoma
        8200/3 Adenoid cystic carcinoma
        8562/3 Epithelial-myoepithelial carcinoma

    Preinvasive lesions
        8070/2 Squamous cell carcinoma in situ, NOS

    Mesenchymal tumors
        9133/1 Epithelioid hemangioendothelioma, NOS
        9120/3 Angiosarcoma
        8973/3 Pleuropulmonary blastoma
        9220/0 Chondroma, NOS
        8827/1 Myofibroblastic tumor, peribronchial
        8825/1 Inflammatory myofibroblastic tumor
        9174/1 Lymphangiomyomatosis
        9040/3 Synovial sarcoma, NOS
            9041/3 Synovial sarcoma, spindle cell
            9043/3 Synovial sarcoma, biphasic
        8800/3 Sarcoma, NOS

Benign epithelial tumors
        8052/0 Squamous cell papilloma, NOS
        8053/0 Squamous cell papilloma, inverted
        8560/0 Mixed squamous cell and glandular papilloma

        8251/0 Alveolar adenoma
        8260/0 Papillary adenoma, NOS
        8140/0 Adenoma, NOS
        8940/0 Pleomorphic adenoma
        8470/0 Mucinous cystic neoplasm (MCN) with low- or intermediate-grade dysplasia

Lymphoproliferative tumors
    9699/3 Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)
    9680/3 Diffuse large B-cell lymphoma (DLBCL), NOS
    9766/1 Lymphomatoid granulomatosis
    9751/3 Langerhans cell histiocytosis

Miscellaneous tumors
    8005/0 Clear cell tumor, NOS
    9080/0 Teratoma, benign
    9080/3 Teratoma, malignant, NOS
    8580/1 Thymoma, NOS
    8720/3 Melanoma, NOS